MedTrace Logo

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

NCT04094818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1441

Last updated 2024-10-22

No results posted yet for this study

Summary

This study will analyze gene expression and other laboratory data from biological samples collected from participants with suspected respiratory, urinary, intra-abdominal, and/or skin \& soft tissue infections; or suspected sepsis of any cause.

Conditions

  • Respiratory Tract Infections
  • Urinary Tract Infections
  • Intra-Abdominal Infections
  • Skin and Soft Tissue Infection
  • Suspected Meningitis/Encephalitis or Any Other Infection
  • Sepsis

Interventions

DIAGNOSTIC_TEST

TriVerity

Blood collection for mRNA analysis, Procalcitonin and CRP determination, molecular analysis of nasopharyngeal swab collection and sputum/ BAL sample collection

Sponsors & Collaborators

  • Inflammatix

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-28
Primary Completion
2024-08-06
Completion
2024-09-30

Countries

  • United States
  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04094818 on ClinicalTrials.gov